Kyle Bass has lost another one of his inter partes review petitions. (If you need reminding who Kyle Bass is, see here and here.) I’m on a panel this coming Tuesday (9/8/2015) with a couple of people from the pharmaceutical industry. It’ll be interesting to see if they back off their attacks on inter partes review.
Tag Archive for inter partes review
An Article About the PTAB You Must Read
by Matt Levy •
I’ve written about a number of times (e.g., here, here, and here) because it’s an incredibly useful tool for dealing with bad patents. Now, Scott Graham and Lisa Shuchman have done a great piece at law.com on the judges at the Patent Trial and Appeals Board (registration required) that I strongly recommend. Here’s a taste, but…
I Called It: Kyle Bass’s First Two IPR Petitions Fail
by Matt Levy •
Kyle Bass, the hedge fund manager who filed a number of inter partes review petitions against pharmaceutical companies, has struck terror into the shriveled hearts of the pharmaceutical industry. The first petitions he filed were against Acorda Therapeutics, and its stock dropped on the news. The pharmaceutical industry immediately started lobbying to change IPR procedures…
Inter Partes Review and Pharma
by Matt Levy •
Here’s a video I’ve done to explain why the pharmaceutical companies’ campaign against inter partes review is disingenuous at best: You can read more about IPRs here. Note: There was a comment on Twitter pointing out that I don’t discuss Kyle Bass and his hedge fund’s attacks against some pharmaceutical patents using inter partes review.…
Three Crucial Words in Patent Reform: Inter Partes Review (Part 3)
by Matt Levy •
Note: This is Part 3 in a three-part series. If you’re not comfortable with how inter partes review works, you may want to start with Part 1. If you are comfortable with IPRs, start with Part 2. Gutting Inter Partes Review Pharmaceutical and biotech companies are pushing for major changes to inter partes reviews (IPRs). First, they…
Three Crucial Words in Patent Reform: Inter Partes Review (Part 2)
by Matt Levy •
Note: This is Part 2 in a three-part series. If you’re not comfortable with how inter partes review works, you may want to start with Part 1. The Complaints About Inter Partes Review (IPR) Some patent owners are complaining that IPRs are unfair to them. The biggest complaint is that too many patents are being invalidated. As…
Three Crucial Words in Patent Reform: Inter Partes Review (Part 1)
by Matt Levy •
Note: This is Part 1 in a three-part series. If you’re already comfortable with how inter partes review works, you may want to skip to Part 2. If you watched the Senate hearing last week, you heard a lot of talk about . Inter partes review (IPR) is an incredibly useful procedure created by the…